Most of them concur that ACE2 and transmembrane protease, serine 2 - TMPRSS2 proteins are established in pancreatic ducts and microvasculature endothelial cells, which could promote indirect impairment of pancreatic endocrine function in COVID-19 (73). This evidence concerns the gene ACE2 and COVID-19.